Cargando…
Orthopaedic management of Hurler’s disease after hematopoietic stem cell transplantation: a systematic review
OBJECTIVE: The introduction of hematopoietic stem cell transplantation (HSCT) has significantly improved the life-span of Hurler patients (mucopolysaccharidosis type I-H, MPS I-H). Yet, the musculoskeletal manifestations seem largely unresponsive to HSCT. In order to facilitate evidence based manage...
Autores principales: | van der Linden, Marleen H., Kruyt, Moyo C., Sakkers, Ralph J. B., de Koning, Tom J., Öner, F. Cumhur, Castelein, René M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109254/ https://www.ncbi.nlm.nih.gov/pubmed/21416194 http://dx.doi.org/10.1007/s10545-011-9304-x |
Ejemplares similares
-
Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation
por: Polgreen, Lynda E., et al.
Publicado: (2019) -
Enzyme replacement therapy in Hurler syndrome after failure of hematopoietic transplant
por: Arranz, Leonor, et al.
Publicado: (2015) -
Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation
por: Schmidt, Mona, et al.
Publicado: (2016) -
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure
por: Boelens, J J, et al.
Publicado: (2007) -
Assessment of Posterolateral Lumbar Fusion: A Systematic Review of Imaging-Based Fusion Criteria
por: Lehr, A. Mechteld, et al.
Publicado: (2022)